Welcome to LookChem.com Sign In|Join Free
  • or
(3α,5α)-3-(acetyloxy)pregnan-20-one is a steroidal compound belonging to the pregnane family, characterized by its unique structure with a 3α,5α-configuration and an acetyloxy group at the 3-position. This chemical is a derivative of pregnane, a naturally occurring steroid that serves as a precursor to various hormones, including progesterone and other corticosteroids. The acetyloxy group at the 3-position in (3α,5α)-3-(acetyloxy)pregnan-20-one suggests that it may have potential applications in pharmaceuticals or as an intermediate in the synthesis of other steroidal compounds. Its specific biological activity and potential therapeutic uses would depend on further research and development, as the presence of the acetyloxy group could influence its interactions with biological targets.

6003-24-3

Post Buying Request

6003-24-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6003-24-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 6003-24-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,0,0 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 6003-24:
(6*6)+(5*0)+(4*0)+(3*3)+(2*2)+(1*4)=53
53 % 10 = 3
So 6003-24-3 is a valid CAS Registry Number.

6003-24-3Relevant academic research and scientific papers

HELIX 12 DIRECTED STEROIDAL PHARMACEUTICAL PRODUCTS

-

Page/Page column 139, (2010/02/12)

Compounds having the structure or their salts: are used to treat or reduce le likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. They can be formulated together with pharmaceutically acceptable diluent or carrier or otherwise made into any pharmaceutical dosage form. Some of these compounds having tissue-specific antiandrogenic activity and tissue-specific androgenic activity can be used to treat or reduce the risk of developing diseases related to loss of androgenic stimulation. Combinations with other active pharmaceutical agents are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6003-24-3